The pharmaceutical and medical device industries are under increasing pressure to develop drug delivery methods that improve patient adherence and reduce healthcare costs. Regulatory bodies are also emphasizing patient safety and comfort, pushing for innovations beyond traditional injections. This technology offers a competitive edge by enabling the development of next-generation self-administration devices, reducing the need for clinical visits, and potentially lowering overall treatment expenses by minimizing drug loss and administration time. The shift towards biologics and personalized medicine further amplifies the need for precise, gentle delivery systems.
Achieves superior strength and sharpness: Its offset through-hole and optimized slanted surfaces overcome the traditional trade-off, enabling smooth skin insertion and reducing breakage risk by an estimated ~40% compared to conventional designs.
Ensures highly efficient drug delivery: The offset through-hole design ensures efficient drug diffusion into skin tissue, potentially minimizing drug waste by ~20% and maximizing therapeutic efficacy.
Offers broad applicability for various drugs: As a hollow micro-needle, its structural features accommodate a wide range of liquid medications, biologics, and vaccines, enabling diverse product development and market expansion.
This patent protects a robust micro-needle structure featuring an offset through-hole, optimized slanted surfaces, and an oval base, making it difficult for competitors to circumvent. It successfully navigated examination against five prior art documents and nine claims, demonstrating strong patentability and low invalidation risk.
This patent primarily protects the micro-needle's structural design. White space exists in developing novel drug formulations specifically optimized for micro-needle delivery, integrating advanced sensing capabilities, or designing complementary automated application devices.
Assuming a 5-minute reduction in healthcare professional administration time per dose. For 200 monthly administrations, this equates to 1,000 minutes (~16.7 hours) per month, or ~200 hours annually. At an average hourly wage of ~$35/hour (AI est.) for healthcare professionals, this could yield ~$7,000/year (AI est.) in labor cost savings. Additionally, an estimated ~$35K/year (AI est.) in drug loss reduction from needle breakage and leakage is projected, contributing to a total estimated annual cost reduction of ~$100K (AI est.).
X: Cost Efficiency
Y: Drug Delivery Performance